The Typhoid Fever drugs in development market research report provides comprehensive information on the therapeutics under development for Typhoid Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Typhoid Fever. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued products.
GlobalData tracks 15 drugs in development for Typhoid Fever by 15 companies/universities/institutes. The top development phase for Typhoid Fever is preclinical with four drugs in that stage. The Typhoid Fever pipeline has 12 drugs in development by companies and three by universities/ institutes. Some of the companies in the Typhoid Fever pipeline products market are: International Vaccine Institute, GSK and Prokarium.
The key targets in the Typhoid Fever pipeline products market include Salmonella Typhi Capsular Vi Polysaccharide Antigen, Polysaccharide, and Streptococcus pneumoniae Pneumococcal Surface Protein A.
The key mechanisms of action in the Typhoid Fever pipeline product include The Typhoid Fever pipeline products include five routes of administration with the top ROA being Intramuscular and five key molecule types in the Typhoid Fever pipeline products market including Conjugate Vaccine, and Live Attenuated Vaccine.
Typhoid Fever overview
Typhoid fever is an infection that causes diarrhea and a rash. It is most commonly due to a type of bacterium called Salmonella typhi. Symptoms include abdominal tenderness, agitation, chills, delirium, hallucinations, severe fatigue, and weakness. Treatment includes antibiotics and supportive therapy.
For a complete picture of Typhoid Fever’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
